Tolterodine Tartrate Patent Expiration
Tolterodine Tartrate was first introduced by Upjohn Us 2 Llc
Tolterodine Tartrate Patents
Given below is the list of patents protecting Tolterodine Tartrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Detrol La |
US6630162 (Pediatric) | Pharmaceutical formulation and its use |
May 11, 2020
(Expired) | Upjohn |
| Detrol La |
US6911217 (Pediatric) | Controlled release bead, a method of producing the same and multiple unit formulation comprising it |
May 11, 2020
(Expired) | Upjohn |
| Detrol La |
US6770295 (Pediatric) | Therapeutic formulation for administering tolterodine with controlled release |
Feb 26, 2020
(Expired) | Upjohn |
| Detrol La | US6630162 | Pharmaceutical formulation and its use |
Nov 11, 2019
(Expired) | Upjohn |
| Detrol La | US6911217 | Controlled release bead, a method of producing the same and multiple unit formulation comprising it |
Nov 11, 2019
(Expired) | Upjohn |
| Detrol La | US6770295 | Therapeutic formulation for administering tolterodine with controlled release |
Aug 26, 2019
(Expired) | Upjohn |
| Detrol |
US5382600 (Pediatric) | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
Sep 25, 2012
(Expired) | Upjohn |
| Detrol La |
US5382600 (Pediatric) | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
Sep 25, 2012
(Expired) | Upjohn |
Tolterodine Tartrate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List